
Pfizer (PFE) Latest News & Updates
Explore latest Pfizer (PFE) News and Updates
Stay updated on Pfizer (PFE) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Pfizer (PFE)
Order type
Buy in
Order amount
Est. shares
0 shares


The Motley Fool •

Business Wire •

Seeking Alpha •

Seeking Alpha •

InvestorPlace •

The Motley Fool •




Zacks Investment Research •



U.S. FDA Approves Pfizer's XELJANZ® (tofacitinib) for the Treatment of Active Ankylosing Spondylitis
Business Wire •

Benzinga •

Zacks Investment Research •

Zacks Investment Research •

Proactive Investors •

Business Insider •

Business Insider •


Proactive Investors •

Market Watch •

